JP2014129323A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2014129323A5 JP2014129323A5 JP2013113122A JP2013113122A JP2014129323A5 JP 2014129323 A5 JP2014129323 A5 JP 2014129323A5 JP 2013113122 A JP2013113122 A JP 2013113122A JP 2013113122 A JP2013113122 A JP 2013113122A JP 2014129323 A5 JP2014129323 A5 JP 2014129323A5
- Authority
- JP
- Japan
- Prior art keywords
- composition
- liver
- composition according
- fatty liver
- maltitol
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000000203 mixture Substances 0.000 claims 15
- 208000004930 Fatty Liver Diseases 0.000 claims 5
- 206010019708 Hepatic steatosis Diseases 0.000 claims 5
- VQHSOMBJVWLPSR-WUJBLJFYSA-N Maltitol Chemical compound OC[C@H](O)[C@@H](O)[C@@H]([C@H](O)CO)O[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O VQHSOMBJVWLPSR-WUJBLJFYSA-N 0.000 claims 5
- 239000000845 maltitol Substances 0.000 claims 5
- 229940035436 maltitol Drugs 0.000 claims 5
- 235000010449 maltitol Nutrition 0.000 claims 5
- 231100000240 steatosis hepatitis Toxicity 0.000 claims 5
- 210000004185 Liver Anatomy 0.000 claims 4
- 239000004480 active ingredient Substances 0.000 claims 3
- 240000007049 Juglans regia Species 0.000 claims 2
- 235000009496 Juglans regia Nutrition 0.000 claims 2
- AHLPHDHHMVZTML-BYPYZUCNSA-N L-ornithine Chemical compound NCCC[C@H](N)C(O)=O AHLPHDHHMVZTML-BYPYZUCNSA-N 0.000 claims 2
- 240000004678 Panax pseudoginseng Species 0.000 claims 2
- 235000003140 Panax quinquefolius Nutrition 0.000 claims 2
- LUKBXSAWLPMMSZ-OWOJBTEDSA-N Resveratrol Natural products C1=CC(O)=CC=C1\C=C\C1=CC(O)=CC(O)=C1 LUKBXSAWLPMMSZ-OWOJBTEDSA-N 0.000 claims 2
- XOAAWQZATWQOTB-UHFFFAOYSA-N Taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 claims 2
- 239000003795 chemical substances by application Substances 0.000 claims 2
- 235000008434 ginseng Nutrition 0.000 claims 2
- 235000005035 ginseng Nutrition 0.000 claims 2
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 claims 2
- 235000012054 meals Nutrition 0.000 claims 2
- 239000008194 pharmaceutical composition Substances 0.000 claims 2
- 230000002265 prevention Effects 0.000 claims 2
- 235000020234 walnut Nutrition 0.000 claims 2
- JLPULHDHAOZNQI-ZTIMHPMXSA-N 1-hexadecanoyl-2-(9Z,12Z-octadecadienoyl)-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCC\C=C/C\C=C/CCCCC JLPULHDHAOZNQI-ZTIMHPMXSA-N 0.000 claims 1
- MQZIGYBFDRPAKN-QISQUURKSA-N 6-hydroxy-3-[(1E,3E,5E,7E,9E,11E,13E,15E,17E)-18-(4-hydroxy-2,6,6-trimethyl-3-oxocyclohexen-1-yl)-3,7,12,16-tetramethyloctadeca-1,3,5,7,9,11,13,15,17-nonaenyl]-2,4,4-trimethylcyclohex-2-en-1-one Chemical compound CC=1C(=O)C(O)CC(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)C(=O)C(O)CC1(C)C MQZIGYBFDRPAKN-QISQUURKSA-N 0.000 claims 1
- 102100019961 ATP7B Human genes 0.000 claims 1
- 101700032974 ATP7B Proteins 0.000 claims 1
- 208000005652 Acute fatty liver of pregnancy Diseases 0.000 claims 1
- 229960003767 Alanine Drugs 0.000 claims 1
- 102000015427 Angiotensins Human genes 0.000 claims 1
- 108010064733 Angiotensins Proteins 0.000 claims 1
- 240000002900 Arthrospira platensis Species 0.000 claims 1
- 235000016425 Arthrospira platensis Nutrition 0.000 claims 1
- 229960005261 Aspartic Acid Drugs 0.000 claims 1
- 241000195649 Chlorella <Chlorellales> Species 0.000 claims 1
- 208000005581 Cirrhosis, Familial, with Pulmonary Hypertension Diseases 0.000 claims 1
- 240000007154 Coffea arabica Species 0.000 claims 1
- 244000163122 Curcuma domestica Species 0.000 claims 1
- 235000003392 Curcuma domestica Nutrition 0.000 claims 1
- 240000008966 Cynara cardunculus Species 0.000 claims 1
- 235000019106 Cynara scolymus Nutrition 0.000 claims 1
- 229960002433 Cysteine Drugs 0.000 claims 1
- 206010012601 Diabetes mellitus Diseases 0.000 claims 1
- 206010058108 Dyslipidaemia Diseases 0.000 claims 1
- 229920000855 Fucoidan Polymers 0.000 claims 1
- 240000008397 Ganoderma lucidum Species 0.000 claims 1
- 235000001637 Ganoderma lucidum Nutrition 0.000 claims 1
- 208000002705 Glucose Intolerance Diseases 0.000 claims 1
- 240000004670 Glycyrrhiza echinata Species 0.000 claims 1
- 235000001453 Glycyrrhiza echinata Nutrition 0.000 claims 1
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 claims 1
- 235000017382 Glycyrrhiza lepidota Nutrition 0.000 claims 1
- LPLVUJXQOOQHMX-MYOOOWEVSA-N Glycyrrhizic acid Natural products O=C(O)[C@H]1[C@@H](O)[C@H](O)[C@@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)[C@H](C(=O)O)O2)[C@@H](O[C@@H]2C(C)(C)[C@H]3[C@@](C)([C@H]4C(=O)C=C5[C@](C)([C@]4(C)CC3)CC[C@]3(C)[C@H]5C[C@](C(=O)O)(C)CC3)CC2)O1 LPLVUJXQOOQHMX-MYOOOWEVSA-N 0.000 claims 1
- 239000004378 Glycyrrhizin Substances 0.000 claims 1
- 208000002972 Hepatolenticular Degeneration Diseases 0.000 claims 1
- 206010062060 Hyperlipidaemia Diseases 0.000 claims 1
- 206010020772 Hypertension Diseases 0.000 claims 1
- 102000004877 Insulin Human genes 0.000 claims 1
- 108090001061 Insulin Proteins 0.000 claims 1
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 claims 1
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 claims 1
- XUJNEKJLAYXESH-REOHCLBHSA-N L-cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 claims 1
- 102000007330 LDL Lipoproteins Human genes 0.000 claims 1
- 108010007622 LDL Lipoproteins Proteins 0.000 claims 1
- 102100014415 LIPA Human genes 0.000 claims 1
- 101700071157 LIPA Proteins 0.000 claims 1
- 229940078795 Lactoferrin Drugs 0.000 claims 1
- 102000010445 Lactoferrin Human genes 0.000 claims 1
- 108010063045 Lactoferrin Proteins 0.000 claims 1
- 229940067606 Lecithin Drugs 0.000 claims 1
- 229940010454 Licorice Drugs 0.000 claims 1
- 206010061227 Lipid metabolism disease Diseases 0.000 claims 1
- AGBQKNBQESQNJD-SSDOTTSWSA-N Lipoic acid Chemical compound OC(=O)CCCC[C@@H]1CCSS1 AGBQKNBQESQNJD-SSDOTTSWSA-N 0.000 claims 1
- 208000001145 Metabolic Syndrome Diseases 0.000 claims 1
- 208000007944 Nodular Nonsuppurative Panniculitis Diseases 0.000 claims 1
- 208000008338 Non-alcoholic Fatty Liver Disease Diseases 0.000 claims 1
- 206010053219 Non-alcoholic steatohepatitis Diseases 0.000 claims 1
- 208000008589 Obesity Diseases 0.000 claims 1
- 229940041672 Oral Gel Drugs 0.000 claims 1
- 229960003104 Ornithine Drugs 0.000 claims 1
- 241000237502 Ostreidae Species 0.000 claims 1
- 241000282373 Panthera pardus Species 0.000 claims 1
- 240000003444 Paullinia cupana Species 0.000 claims 1
- 208000008425 Protein Deficiency Diseases 0.000 claims 1
- MUPFEKGTMRGPLJ-ZQSKZDJDSA-N Raffinose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO[C@@H]2[C@@H]([C@@H](O)[C@@H](O)[C@@H](CO)O2)O)O1 MUPFEKGTMRGPLJ-ZQSKZDJDSA-N 0.000 claims 1
- MUPFEKGTMRGPLJ-RMMQSMQOSA-N Raffinose Natural products O(C[C@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@@H](O[C@@]2(CO)[C@H](O)[C@@H](O)[C@@H](CO)O2)O1)[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 MUPFEKGTMRGPLJ-RMMQSMQOSA-N 0.000 claims 1
- 240000000947 Rumex vesicarius Species 0.000 claims 1
- 229940081973 S-Adenosylmethionine Drugs 0.000 claims 1
- MEFKEPWMEQBLKI-AIRLBKTGSA-O S-adenosyl-L-methionine zwitterion Chemical compound O[C@@H]1[C@H](O)[C@@H](C[S+](CC[C@H]([NH3+])C([O-])=O)C)O[C@H]1N1C2=NC=NC(N)=C2N=C1 MEFKEPWMEQBLKI-AIRLBKTGSA-O 0.000 claims 1
- PEYUIKBAABKQKQ-AFHBHXEDSA-N Sesamin Chemical compound C1=C2OCOC2=CC([C@H]2OC[C@H]3[C@@H]2CO[C@@H]3C2=CC=C3OCOC3=C2)=C1 PEYUIKBAABKQKQ-AFHBHXEDSA-N 0.000 claims 1
- 240000003670 Sesamum indicum Species 0.000 claims 1
- 235000003434 Sesamum indicum Nutrition 0.000 claims 1
- 229940069764 Shark liver oil Drugs 0.000 claims 1
- SEBFKMXJBCUCAI-HKTJVKLFSA-N Silibinin Chemical compound C1=C(O)C(OC)=CC([C@@H]2[C@H](OC3=CC=C(C=C3O2)[C@@H]2[C@H](C(=O)C3=C(O)C=C(O)C=C3O2)O)CO)=C1 SEBFKMXJBCUCAI-HKTJVKLFSA-N 0.000 claims 1
- 241000320380 Silybum Species 0.000 claims 1
- 235000010841 Silybum marianum Nutrition 0.000 claims 1
- 229940082787 Spirulina Drugs 0.000 claims 1
- 240000001949 Taraxacum officinale Species 0.000 claims 1
- 229960003080 Taurine Drugs 0.000 claims 1
- 235000001484 Trigonella foenum graecum Nutrition 0.000 claims 1
- 240000005216 Trigonella foenum-graecum Species 0.000 claims 1
- 240000006365 Vitis vinifera Species 0.000 claims 1
- 235000014787 Vitis vinifera Nutrition 0.000 claims 1
- 206010047883 Weber-Christian disease Diseases 0.000 claims 1
- 201000001203 Wilson disease Diseases 0.000 claims 1
- 206010053687 Wolman's disease Diseases 0.000 claims 1
- 238000009825 accumulation Methods 0.000 claims 1
- 229960001570 ademetionine Drugs 0.000 claims 1
- 235000004279 alanine Nutrition 0.000 claims 1
- 230000000111 anti-oxidant Effects 0.000 claims 1
- 239000003524 antilipemic agent Substances 0.000 claims 1
- 239000003963 antioxidant agent Substances 0.000 claims 1
- 235000006708 antioxidants Nutrition 0.000 claims 1
- 235000016520 artichoke thistle Nutrition 0.000 claims 1
- 235000003704 aspartic acid Nutrition 0.000 claims 1
- 235000013793 astaxanthin Nutrition 0.000 claims 1
- 229940022405 astaxanthin Drugs 0.000 claims 1
- 239000001168 astaxanthin Substances 0.000 claims 1
- 235000013361 beverage Nutrition 0.000 claims 1
- 239000002775 capsule Substances 0.000 claims 1
- 235000016213 coffee Nutrition 0.000 claims 1
- 235000013353 coffee beverage Nutrition 0.000 claims 1
- 235000003373 curcuma longa Nutrition 0.000 claims 1
- 235000015422 curly dock Nutrition 0.000 claims 1
- 235000015426 curly dock Nutrition 0.000 claims 1
- 235000018417 cysteine Nutrition 0.000 claims 1
- 235000009242 dandelion Nutrition 0.000 claims 1
- 235000014079 dandelion Nutrition 0.000 claims 1
- 201000010099 disease Diseases 0.000 claims 1
- 239000002552 dosage form Substances 0.000 claims 1
- 235000013305 food Nutrition 0.000 claims 1
- 235000020510 functional beverage Nutrition 0.000 claims 1
- 235000013376 functional food Nutrition 0.000 claims 1
- 229960004949 glycyrrhizic acid Drugs 0.000 claims 1
- 235000019410 glycyrrhizin Nutrition 0.000 claims 1
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 claims 1
- 239000008187 granular material Substances 0.000 claims 1
- 235000021242 lactoferrin Nutrition 0.000 claims 1
- 239000000787 lecithin Substances 0.000 claims 1
- 235000010445 lecithin Nutrition 0.000 claims 1
- 235000014063 licorice root Nutrition 0.000 claims 1
- 235000009408 lignans Nutrition 0.000 claims 1
- 229930013686 lignans Natural products 0.000 claims 1
- 235000019136 lipoic acid Nutrition 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- 239000000463 material Substances 0.000 claims 1
- 235000001411 milk thistle Nutrition 0.000 claims 1
- 238000002156 mixing Methods 0.000 claims 1
- 239000002324 mouth wash Substances 0.000 claims 1
- 235000020824 obesity Nutrition 0.000 claims 1
- -1 oral jelly Substances 0.000 claims 1
- 239000000668 oral spray Substances 0.000 claims 1
- 239000007935 oral tablet Substances 0.000 claims 1
- 235000020636 oyster Nutrition 0.000 claims 1
- 235000012361 paullinia cupana Nutrition 0.000 claims 1
- 229960001109 policosanol Drugs 0.000 claims 1
- 150000008442 polyphenolic compounds Chemical class 0.000 claims 1
- 235000013824 polyphenols Nutrition 0.000 claims 1
- 239000000843 powder Substances 0.000 claims 1
- 239000002464 receptor antagonist Substances 0.000 claims 1
- 235000021283 resveratrol Nutrition 0.000 claims 1
- 229940016667 resveratrol Drugs 0.000 claims 1
- 229940109850 royal jelly Drugs 0.000 claims 1
- 231100000489 sensitizer Toxicity 0.000 claims 1
- 239000010686 shark liver oil Substances 0.000 claims 1
- 235000017700 silymarin Nutrition 0.000 claims 1
- 229960004245 silymarin Drugs 0.000 claims 1
- 239000000243 solution Substances 0.000 claims 1
- 230000001629 suppression Effects 0.000 claims 1
- 239000006188 syrup Substances 0.000 claims 1
- 235000020357 syrup Nutrition 0.000 claims 1
- 239000003826 tablet Substances 0.000 claims 1
- 229960002663 thioctic acid Drugs 0.000 claims 1
- 235000001019 trigonella foenum-graecum Nutrition 0.000 claims 1
- 235000013976 turmeric Nutrition 0.000 claims 1
Claims (14)
- マルチトールを有効成分として含有する、肝臓への脂肪蓄積抑制用組成物。
- マルチトールを有効成分として含有する、脂肪肝の予防および/または治療のための組成物。
- 脂肪肝が非アルコール性脂肪肝または非アルコール性脂肪肝炎である、請求項2に記載の組成物。
- 肥満、糖尿病、脂質異常症、高脂血症、高血圧、耐糖能異常症、メタボリックシンドローム、脂肪ジストロフィー症、βリポ蛋白欠損症、ウェーバー−クリスチャン病、ウォルマン病、妊娠性急性脂肪肝、ウィルソン病およびインド小児肝硬変からなる群より選ばれる1種以上の疾患に罹患した患者における脂肪肝の予防および/または治療のための、請求項2または3に記載の組成物。
- 脂肪含有量が10重量%以上である食事の食前、食中、食後および食間のいずれかに投与されるものである、請求項2〜4いずれかに記載の組成物。
- 錠剤、カプセル剤、顆粒剤、散剤、経口液剤、シロップ剤、経口ゼリー剤、口腔用錠剤、口腔用スプレー剤、口腔用半固形剤および含嗽剤からなる群より選ばれる剤形のものである、請求項1〜5いずれかに記載の組成物。
- インスリン抵抗性改善薬、抗酸化剤、脂質異常症治療薬、肝庇護薬およびアンジオテンシンII1型受容体拮抗薬からなる群より選ばれる1種以上の薬剤をさらに含む、請求項1〜6いずれかに記載の組成物。
- 組成物が機能性飲食品である、請求項1〜5のいずれかに記載の組成物。
- 組成物がサプリメントである、請求項1〜6のいずれかに記載の組成物。
- 組成物が医薬組成物である、請求項2〜7のいずれかに記載の組成物。
- 動物肝臓、サメの肝油、豚肝臓の酵素分解ペプチド、ポリコサノール、葛花、L−オルニチン、ノブドウ、レスベラトロール、クルミ、クルミポリフェノール、α−リポ酸、アーティチョーク、アスタキサンチン、アスパラギン酸、アラニン、イエロードック、ウコン、牡蠣、ガジュツ、ガラナ、甘草、キョウオウ、クロレラ、グリチルリチン、高麗人参、コーヒー、ゴマリグナン、S-アデノシルメチオニン、シジミ、システイン、シリマリン、スピルリナ、チャンカピエドラ、田七人参、フェヌグリーク、セサミン、タウリン、ダンデライオン、フコイダン、マリアアザミ、ラクトフェリン、ラフィノース、霊芝、レシチンおよびローヤルゼリーからなる群より選ばれる1種以上の天然物または天然由来物質をさらに含む、請求項1〜10いずれかに記載の組成物。
- 非ヒト動物における脂肪肝の予防および/または治療のための、マルチトールを有効成分として含有する非ヒト動物用医薬組成物。
- マルチトールを非ヒト動物に投与することを含む、非ヒト動物における脂肪肝を予防および/または治療する方法。
- マルチトールを飲食品に配合または添加することを特徴とする、機能性飲食品の製造方法。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2013113122A JP6157928B2 (ja) | 2012-05-29 | 2013-05-29 | 肝臓への脂肪蓄積抑制剤 |
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2012122255 | 2012-05-29 | ||
JP2012122255 | 2012-05-29 | ||
JP2012263122 | 2012-11-30 | ||
JP2012263122 | 2012-11-30 | ||
JP2013113122A JP6157928B2 (ja) | 2012-05-29 | 2013-05-29 | 肝臓への脂肪蓄積抑制剤 |
Publications (3)
Publication Number | Publication Date |
---|---|
JP2014129323A JP2014129323A (ja) | 2014-07-10 |
JP2014129323A5 true JP2014129323A5 (ja) | 2016-07-21 |
JP6157928B2 JP6157928B2 (ja) | 2017-07-05 |
Family
ID=51408083
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2013113122A Active JP6157928B2 (ja) | 2012-05-29 | 2013-05-29 | 肝臓への脂肪蓄積抑制剤 |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP6157928B2 (ja) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP6437183B2 (ja) * | 2012-11-30 | 2018-12-12 | 上野製薬株式会社 | 肝機能改善剤 |
KR101981534B1 (ko) * | 2017-09-01 | 2019-05-23 | (주)솔빛피앤에프 | 프로텍틴 dx를 유효성분으로 함유하는 고지혈증 또는 지방간 질환 예방 또는 치료용 조성물 |
WO2019092569A1 (en) * | 2017-11-09 | 2019-05-16 | Nestec Sa | Nutrition blend for health benefits in animals |
KR102212264B1 (ko) * | 2019-02-26 | 2021-02-04 | (주)에코인베스트 | 흰민들레 및 엉겅퀴를 포함하는 지방간 출혈 증후군 완화용 사료 첨가제 |
JP7403241B2 (ja) * | 2019-06-07 | 2023-12-22 | 小林製薬株式会社 | 内臓脂肪の視認性向上方法 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH0399018A (ja) * | 1989-09-11 | 1991-04-24 | Otsuka Pharmaceut Co Ltd | グルカゴン様ペプチドホルモン分泌促進剤 |
KR20090003282A (ko) * | 2006-03-31 | 2009-01-09 | 메이지 데어리즈 코포레이션 | 항지방축적용 조성물 |
JP2013113125A (ja) * | 2011-11-25 | 2013-06-10 | Yamada Seisakusho Co Ltd | 内接歯車式ポンプ |
-
2013
- 2013-05-29 JP JP2013113122A patent/JP6157928B2/ja active Active
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Torres-Fuentes et al. | A natural solution for obesity: Bioactives for the prevention and treatment of weight gain. A review | |
US8815310B2 (en) | Compositions for boosting metabolism, assisting weight loss, and promoting cardiovascular health | |
JP2014129323A5 (ja) | ||
JPWO2008143182A1 (ja) | 甘草ポリフェノールを含有する組成物 | |
ES2788166T3 (es) | Composiciones y métodos que utilizan un polifenol para la salud musculo esquelética | |
JP2008542300A (ja) | 炎症と関連した状態を予防及び治療するための組成物及び方法 | |
JP6446552B2 (ja) | 体重と体脂肪減少に用いられる組成物およびその医薬品と使用 | |
JP2017515499A5 (ja) | ||
JP6086953B2 (ja) | Ampk活性化剤 | |
JP6157928B2 (ja) | 肝臓への脂肪蓄積抑制剤 | |
CN107580496B (zh) | 绞股蓝皂苷75的抗糖尿效果 | |
JP6293099B2 (ja) | ジンセノサイドf2の肝疾患予防又は治療用途 | |
JP4468837B2 (ja) | 抗肥満剤 | |
JP6161438B2 (ja) | 脂肪蓄積抑制及び/又は脂肪蓄積量低減剤 | |
CN104055773B (zh) | 一种降血脂组合物及其应用 | |
JP6660668B2 (ja) | Ucp−1発現促進剤 | |
WO2016068267A1 (ja) | シックネスビヘイビア症状改善剤 | |
JP2014129324A5 (ja) | ||
JP6553375B2 (ja) | Ucp−1発現促進剤 | |
JP5576699B2 (ja) | Gip上昇抑制剤 | |
KR101358197B1 (ko) | 특정 화합물을 유효성분으로 포함하는 렙틴 분비 촉진용 조성물 | |
JP2007320900A (ja) | 内臓脂肪蓄積抑制剤及び、血中アディポネクチン濃度増加促進及び/又は減少抑制剤 | |
KR101660834B1 (ko) | 지페노사이드 75의 항당뇨 효과 | |
US20220265603A1 (en) | Hepatic fibrosis-inhibiting agent and brown fat cell-activating agent containing taxifolin | |
JP6437183B2 (ja) | 肝機能改善剤 |